Compare Abbott Laboratories (ABT) vs CleanSpark Inc (CLSK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs CleanSpark Inc — how do they compare? Abbott Laboratories trades at $95.34 (market cap $166.94B), while CleanSpark Inc trades at $12.25 (market cap $3.20B). The key difference: Abbott Laboratories is far larger — about 52.2× CleanSpark Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while CleanSpark Inc pays none. Which is the better fit depends on your goals.
| ABT | CLSK | |
|---|---|---|
Market Cap | $166.94B | $3.20B |
Sector | Health | Technology |
52-Week High | $136.62 | $23.20 |
52-Week Low | $82.57 | $8.18 |
Enterprise Value | $193.69B | $4.06B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CleanSpark (CLSK) trades at $13.51, up 7.05% today but facing bearish technical signals with recent earnings misses. The company reported strong revenue growth to $766M in 2025 but swung to a net loss margin of -67.66% in 2026. Analyst sentiment remains strongly bullish with 11 buy ratings and a $20.50 consensus target, though cash flow challenges persist with negative operating cash flow of $461M in 2025.
The stock presents a divergence between strong analyst support and challenging fundamentals. While Wall Street sees 100% upside potential, investors face execution risks from profitability challenges and volatile bitcoin mining economics. The technical setup suggests near-term pressure with the stock trading near support levels amid broader market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About CleanSpark Inc
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →
